Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan

Hepato-Gastroenterology

Volumn 53, Issue 69, 2006, Pages 348-350

  Shen, Yeh You ^a,c   Liang, Ji An ^b   Chen, Yen Kung ^a   Tsai, Chun Yueh ^b   Kao, Chia Hung ^b  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

18F fluoro 2 deoxyglucose positron emission tomography; Carcinoembryonic antigen (CEA); Recurrent colorectal cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL SURGERY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECTUM BIOPSY; TAIWAN; ABDOMINAL TUMOR; BLOOD; COLORECTAL TUMOR; LABORATORY DIAGNOSIS; LIVER TUMOR; LUNG TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; SCINTISCANNING; TUMOR RECURRENCE;

ABDOMINAL NEOPLASMS; ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TAIWAN;

EID: 33745465084     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Moertel CG, Fleming TR, Macdonald JS, et al: An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patient with resection colon cancer. JAMA 1993; 270:943-947.
2. Vernava AM III, Longo WE, Virgo KS, et al: Current follow-up strategies after resection of colon cancer. Results of a survey of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1994; 37:573-583.
3. Sagar PM, Pemberton JH: Surgical management of locally recurrent rectal cancer. Br J Surg 1996; 83:293-304.
4. Kelly CJ, Daly JM: Colorectal cancer. Principles of postoperative follow-up. Cancer 1992; 70:1397-1408.
5. Flamen P, Hoekstra OS, Homans F, et al: Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). Eur J Cancer 2001; 37:862-869.
6. Flanagan FL, Dehdashti F, Ogunbiyi OA, et al: Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998; 227:319-323.
7. 18F-fluoro-2- deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer. Anticancer Res 2001; 21:1375-1378.
8. Strauss LG, Clorius JH, Schlag P, et al: Recurrent of colorectal tumors: PET evaluation. Radiology 1989; 170:329-332.
9. Dahlbom M, Hoffman EJ, Hoh CK: Whole-body positron emission tomography: Part I. Methods and performance characteristics. J Nucl Med 1992; 33:1191-1199.
10. Goldberg MA, Lee MJ, Fischman AJ, et al: Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging. Radiographics 1993; 13:1047-1062.
11. Shields AF, Graham MM, Spence AM: The role of PET imaging in clinical oncology: a current status report. In: Freeman LM (Ed.). Nuclear Medicine Annual. New York: Raven Press, 1995; pp. 129-168.
12. Gambhir SS, Czernin J, Schwimmer J, et al: A tabulated summary of the FDG-PET literature. J Nucl Med 2001; 42:1S-93S.
13. Berger KL, Nicholson SA, Dehdashti F, Siegel BA: FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol 2000; 174:1005-1008.
14. Miraldi F, Vesselle H, Faulhaber PE, et al: Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer. Clin Nucl Med 1998; 23:3-7.
15. Gordon BA, Flanagan FL, Dehdashti F: Whole-body positron emission tomography: normal variations, pitfalls, and technical consideration. Am J Roentgenol 1997; 169:1675-1680.
16. Knight SB, Delbeke D, Stewart JR, Sandler MP: Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 1996; 109:982-988.
17. 18]- fluoro-2-deoxy-D-glucose positron emission tomography studies for evaluation of focal pulmonary abnormalities. J Formos Med Assoc 1998; 97:642-645.